Reports
Sale
United States Speciality Generics Market Size, Share, Trends: By Route of Administration: Injectables, Oral, Others; By Therapeutic Application: Oncology, Hepatitis, Multiple Sclerosis, HIV, Others; By Distribution Channel: Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis; Competitive Landscape; 2024-2032
United States Speciality Generics Market Outlook
The United States speciality generics market attained a value of almost USD 26.28 billion in the year 2023. The market is further expected to grow at a CAGR of 9.6% between 2024 and 2032 to reach a value of almost USD 59.97 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The United States speciality generics market is driven by the rising prevalence of chronic diseases. The industry has witnessed a huge growth in the United States, owing to a growing number of rare disease cases. The industry is thriving in the country with the launch of products by many key industry players, in confluence with the favourable initiatives undertaken by the US FDA like the Breakthrough Therapy, which aims to expand and smoothen the accessibility of these drugs to patients.
Properties and Applications
Speciality drugs are referred to as drugs that require special handling, supervision, or administration. These drugs usually have complex chemical structures and delivery mechanisms, often requiring extensive research and development (R&D). Speciality generics are the generic variants of such branded drugs that have lost the protection of their patent. These prescription medicines are used in the treatment of chronic medical conditions such as cancer, psoriasis, epilepsy, HIV, hepatitis C, multiple sclerosis, rheumatoid arthritis, haemophilia, and inflammatory bowel disease (IBD).
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry is segmented on the basis of route of administration into:
- Injectables
- Oral
- Others
Among these, injectables represent a clear dominance in the industry.
On the basis of therapeutic application, the industry is divided into:
- Oncology
- Hepatitis
- Multiple Sclerosis
- HIV
- Other Autoimmune Diseases
- Others
Currently, oncology holds the majority of the speciality generics market share in the United States.
On the basis of the distribution channel, the industry is segmented into:
- Retail Pharmacies
- Speciality Pharmacies
- Hospital Pharmacies
At present, retail pharmacies hold the dominant position in the industry.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The speciality generics industry in the United States is driven by the rising prevalence of several life-threatening diseases, such as cancer and HIV. In addition to this, an increase in the geriatric population throughout the United States has led to the incidences of several complex diseases, which, inadvertently, is creating a positive outlook for the speciality generics industry. Also, as the manufacturing process of speciality generic drugs does not include marketing and development costs, they are available in the industry at a more affordable price point as opposed to their branded counterparts, which is further propelling the growth of the industry.
Competitive Landscape
The report gives a detailed analysis of the following key players in the United States speciality generics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Akorn, Inc.
- USA Pharmaceuticals & Sports Science
- Amneal Pharmaceuticals LLC.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Route of Administration |
|
| Breakup by Therapeutic Application |
|
| Breakup by Distribution Channel |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 United States
7 Opportunities and Challenges in the Market
8 Global Speciality Generics Market Overview
8.1 Key Industry Highlights
8.2 Global Speciality Generics Historical Market (2018-2023)
8.3 Global Speciality Generics Market Forecast (2024-2032)
8.4 Global Speciality Generics Market by Route of Administration
8.5 Global Speciality Generics Market by Therapeutic Application
8.6 Global Speciality Generics Market by Distribution Channel
8.7 Global Speciality Generics Market by Region
8.7.1 North America
8.7.2 Europe
8.7.3 Asia Pacific
8.7.4 Latin America
8.7.5 Middle East and Africa
9 United States Speciality Generic Market Analysis
9.1 Key Industry Highlights
9.2 United States Speciality Generics Historical Market (2018-2023)
9.3 United States Speciality Generics Market Forecast (2024-2032)
9.4 United States Speciality Generics Market by Route of Administration
9.4.1 Injectables
9.4.1.1 Historical Trend (2018-2023)
9.4.1.2 Forecast Trend (2024-2032)
9.4.2 Oral
9.4.2.1 Historical Trend (2018-2023)
9.4.2.2 Forecast Trend (2024-2032)
9.4.3 Others
9.5 United States Speciality Generics Market by Therapeutic Application
9.5.1 Oncology
9.5.1.1 Historical Trend (2018-2023)
9.5.1.2 Forecast Trend (2024-2032)
9.5.2 Hepatitis
9.5.2.1 Historical Trend (2018-2023)
9.5.2.2 Forecast Trend (2024-2032)
9.5.3 Multiple Sclerosis
9.5.3.1 Historical Trend (2018-2023)
9.5.3.2 Forecast Trend (2024-2032)
9.5.4 HIV
9.5.4.1 Historical Trend (2018-2023)
9.5.4.2 Forecast Trend (2024-2032)
9.5.5 Others
9.6 United States Speciality Generics Market by Distribution Channel
9.6.1 Retail Pharmacies
9.6.1.1 Historical Trend (2018-2023)
9.6.1.2 Forecast Trend (2024-2032)
9.6.2 Speciality Pharmacies
9.6.2.1 Historical Trend (2018-2023)
9.6.2.2 Forecast Trend (2024-2032)
9.6.3 Hospital Pharmacies
9.6.3.1 Historical Trend (2018-2023)
9.6.3.2 Forecast Trend (2024-2032)
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyers Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Akorn, Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Financial Summary
12.2.1.5 Certifications
12.2.2 USA Pharmaceuticals & Sports Science
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Financial Summary
12.2.2.5 Certifications
12.2.3 Amneal Pharmaceuticals LLC.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Financial Summary
12.2.3.5 Certifications
12.2.4 Others
13 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Speciality Generics Market: Key Industry Highlights, 2018 and 2032
2. Global Speciality Generics Historical Market: Breakup by Route of Administration (USD Billion), 2018-2023
3. Global Speciality Generics Market Forecast: Breakup by Route of Administration (USD Billion), 2024-2032
4. Global Speciality Generics Historical Market: Breakup by Therapeutic Application (USD Billion), 2018-2023
5. Global Speciality Generics Market Forecast: Breakup by Therapeutic Application (USD Billion), 2024-2032
6. Global Speciality Generics Historical Market: Breakup by Distribution Channel (USD Billion), 2018-2023
7. Global Speciality Generics Market Forecast: Breakup by Distribution Channel (USD Billion), 2024-2032
8. United States Speciality Generics Market: Key Industry Highlights, 2018 and 2032
9. United States Speciality Generics Historical Market: Breakup by Route of Administration (USD Billion), 2018-2023
10. United States Speciality Generics Market Forecast: Breakup by Route of Administration (USD Billion), 2024-2032
11. United States Speciality Generics Historical Market: Breakup by Therapeutic Application (USD Billion), 2018-2023
12. United States Speciality Generics Market Forecast: Breakup by Therapeutic Application (USD Billion), 2024-2032
13. United States Speciality Generics Historical Market: Breakup by Distribution Channel (USD Billion), 2018-2023
14. United States Speciality Generics Market Forecast: Breakup by Distribution Channel (USD Billion), 2024-2032
15. United States Speciality Generics Market Structure
Key Questions Answered in the Report
In 2023, the speciality generics market in the United States attained a value of nearly USD 26.28 billion.
The market is projected to grow at a CAGR of 9.6% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach around USD 59.97 billion by 2032.
The major drivers of the market are rising prevalence of chronic diseases and affordable prices of specialty generics.
The key trends guiding the growth of the speciality generics market includes an increase in the geriatric population and the favourable initiatives undertaken by the US FDA which aim to expand and smoothen the accessibility of these drugs to patients.
Injectables and oral, among others, are the various routes of administration in the market.
Oncology, hepatitis, multiple sclerosis, and HIV, among others, are the leading therapeutic applications of speciality generics in the United States.
Retail pharmacies, specialty pharmacies, and hospital pharmacies are the leading distribution channels in the market.
The major players in the United States speciality generics market are Akorn, Inc., USA Pharmaceuticals & Sports Science, and Amneal Pharmaceuticals LLC., among others.
Analyst Review
The United States speciality generics market attained a value of USD 26.28 billion in 2023 driven by the growing prevalence of chronic diseases in the country. Aided by the favourable initiatives undertaken by the US FDA, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 9.6%. The speciality generics market in the United States is projected to reach USD 59.97 billion by 2032.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its route of administration, the injectables are the leading segment in the speciality generics industry in the United States. On the basis of therapeutic application, oncology holds the majority of the market. Based on distribution channels, the retail pharmacies sector accounts for the leading share in the industry. The key players in the above market include Akorn, Inc., USA Pharmaceuticals & Sports Science, Amneal Pharmaceuticals LLC., and others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2199
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3299
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4399
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5499
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER